Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II

NCT ID: NCT01706406

Last Updated: 2017-06-01

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 98 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2007-11-30
• Study Completion Date: 2012-06-30

Brief Summary

The purpose of this study is to pilot test and determine the efficacy of a psychoeducational intervention (PED) we recently piloted in a group format for women with acquired sexual arousal disorder (FSAD).

HYPOTHESES:

1. - Compared to baseline measures, the PED will result in significant improvement in self-report measures of: (a) subjective sexual arousal; (b) perception of genital arousal/genital sensitivity; (c) orgasmic experience; (d) sexual desire; (e) sexual distress; (f) relationship satisfaction; (g) depressive symptoms; and (h) quality of life.

2. - It is unknown what effect the PED will have on actual physiological sexual arousal.

3. - The group format will be a feasible and cost-effective method of delivering empirically supported treatment to women with sexual arousal difficulties and will contribute towards meeting the needs for sexual health care for women on the clinic wait-list at the BC Centre for Sexual Medicine.

Detailed Description

Sexual arousal difficulties are common among women, affecting approximately 22% of women between the ages of 18 and 59 (Laumann, Paik & Rosen, 1999). Although there are evidence-based psychological treatments available for women with orgasmic and pain disorders, there are currently no empirically-supported treatments for women with acquired Sexual Arousal Disorder (FSAD). Moreover, there have been numerous attempts to find evidence for a pharmacological agent effective at treating women's sexual arousal complaints; however, to date these studies have been inconclusive. Given the significant role that sexual health plays in quality of life, the fact that effective psychological treatments for women's sexual dysfunction are not widely available, and the fact that wait-lists to see health care professionals with expertise in the area of sexual dysfunction are often unwieldy, there is a need to establish brief, evidence-based approaches to treat women's acquired FSAD. Psychological therapy in a group format is a standard practice at the BC Centre for Sexual Medicine. However, in this study we would like to collect information from participants that would help us in determining the specific efficacy of the PED as well as identifying demographic or participant variables that might predict a positive response to the PED. Because we are using this information to determine the treatment's efficacy and because we will use this information as the basis for a publication, we deem this to be a research trial in which ethics review is necessary.

OBJECTIVES: We have recently developed and tested a new psychoeducational treatment (PED) for the treatment of FSAD due to early-stage gynecologic cancer treatment, and for healthy women with FSAD. Our data show this PED to significantly improve self-reported sexual desire, arousal, mood, relationship distress, and quality of life. We are currently testing the efficacy of this PED in a larger sample of cancer survivors with FSAD. The goal for this study is to determine the efficacy of the group PED for currently seeking treatment at the BC Centre for Sexual Medicine for FSAD. By using a waitlist control group, we can determine if any improvement in sexual function is due to treatment or the passage of time.

Conditions

Low Female Sexual Arousal; Low Female Sexual Desire

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

1 treatment

Women randomized into the "treatment" group will undergo pre-treatment testing (questionnaires and physiological assessment)within 14 days of beginning treatment

Group Type: EXPERIMENTAL

Brief psychoeducational intervention for female sexual arousal disorder

Intervention Type: BEHAVIORAL

four 1.5 hour long group psychoeducational sessions, spaced 2 weeks apart for a total of 8 weeks.

2 waitlist

Women randomized to the "waitlist" group will undergo initial testing (questionnaires and physiological testing) and receive no treatment until the next scheduled group (4 months). They will undergo pretreatment testing and treatment on the same schedule as women in the "treatment" group.

Group Type: OTHER

Brief psychoeducational intervention for female sexual arousal disorder

Intervention Type: BEHAVIORAL

four 1.5 hour long group psychoeducational sessions, spaced 2 weeks apart for a total of 8 weeks.

Interventions

Brief psychoeducational intervention for female sexual arousal disorder

four 1.5 hour long group psychoeducational sessions, spaced 2 weeks apart for a total of 8 weeks.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• between the ages of 19 and 65
• currently seeking treatment at the BC Centre for Sexual Medicine
• meet clinical criteria for acquired Female Sexual Arousal Disorder (FSAD);
• be proficient in English and willing to take part in group sessions.

Exclusion Criteria

• does not meet clinical criteria for acquired Female Sexual Arousal Disorder (FSAD)
• not currently Seeking seeking treatment at the BC Centre for Sexual Medicine

• Minimum Eligible Age: 19 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

University of British Columbia

OTHER

Sponsor Role: lead

Responsible Party

Lori Brotto

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Lori A Brotto, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Locations

BC Centre for Sexual Medicine

Vancouver, British Columbia, Canada

UBC Sexual Health Lab, Vancouver Hospital

Vancouver, British Columbia, Canada

Countries

Canada

Related Links

http://www.obgyn.ubc.ca/SexualHealth

UBC Sexual Health Lab website

Other Identifiers

C05-0400-II

Identifier Type: -

Identifier Source: org_study_id